Clinical Trials Browser

Unknown × Observational × Bortezomib × Clear all

Evaluation of Maintenance With Bortezomib Plus Daratumumab (V-Dara) After Induction With Bortezomib, Melphalan, Prednisone Plus Daratumumab (VMP-Dara) in Newly Diagnosed Multiple Myeloma (MM) Patients Non-eligible for autoSCT

Evaluation of Clinical Treatment of Multiple Myeloma Based on Multi-omics